The SCANDIV trial (Scandinavian Diverticulitis trial) is another key study comparing LPL (101 patients) with primary resection (98 patients) for patients with perforated and purulent peritonitis (Hinchey III) [8]. This evidence concerns the gene LPL and Colonic diverticula.